These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18855915)

  • 1. Local delivery of modified paclitaxel-loaded poly(epsilon-caprolactone)/pluronic F68 nanoparticles for long-term inhibition of hyperplasia.
    Mei L; Sun H; Song C
    J Pharm Sci; 2009 Jun; 98(6):2040-50. PubMed ID: 18855915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model.
    Mei L; Sun H; Jin X; Zhu D; Sun R; Zhang M; Song C
    Pharm Res; 2007 May; 24(5):955-62. PubMed ID: 17372684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surface-modified paclitaxel-loaded nanoparticles as local delivery system for the prevention of vessel restenosis].
    Mei L; Song CX; Jin X; Che YZ; Jin Z; Sun HF
    Yao Xue Xue Bao; 2007 Jan; 42(1):81-6. PubMed ID: 17520813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective antitumor activity of paclitaxel-loaded poly (epsilon-caprolactone)/pluronic F68 nanoparticles after intratumoral delivery into the murine breast cancer model.
    Ma G; Yang J; Zhang L; Song C
    Anticancer Drugs; 2010 Mar; 21(3):261-9. PubMed ID: 20016371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment.
    Zhang Y; Tang L; Sun L; Bao J; Song C; Huang L; Liu K; Tian Y; Tian G; Li Z; Sun H; Mei L
    Acta Biomater; 2010 Jun; 6(6):2045-52. PubMed ID: 19969111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment.
    Mei L; Zhang Y; Zheng Y; Tian G; Song C; Yang D; Chen H; Sun H; Tian Y; Liu K; Li Z; Huang L
    Nanoscale Res Lett; 2009 Sep; 4(12):1530-9. PubMed ID: 20652101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging.
    Ranjan AP; Zeglam K; Mukerjee A; Thamake S; Vishwanatha JK
    Nanotechnology; 2011 Jul; 22(29):295104. PubMed ID: 21693801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
    Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
    J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer.
    Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A
    Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation.
    López-Gasco P; Iglesias I; Benedí J; Lozano R; Teijón JM; Blanco MD
    J Microencapsul; 2011; 28(5):417-29. PubMed ID: 21736526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.
    Wang Y; Hao J; Li Y; Zhang Z; Sha X; Han L; Fang X
    Biomaterials; 2012 Jun; 33(18):4741-51. PubMed ID: 22445254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy.
    Oh KS; Song JY; Cho SH; Lee BS; Kim SY; Kim K; Jeon H; Kwon IC; Yuk SH
    J Control Release; 2010 Dec; 148(3):344-50. PubMed ID: 20797418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS for delivery of paclitaxel to prostate cancer cells.
    Wang K; Guo L; Xiong W; Sun L; Zheng Y
    J Biomater Appl; 2014 Sep; 29(3):329-40. PubMed ID: 24621530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and biological evaluation of paclitaxel loaded biodegradable PCL/PEG nanoparticles for the treatment of human neuroendocrine pancreatic tumor in mice.
    Dubey N; Shukla J; Hazari PP; Varshney R; Ganeshpurkar A; Mishra AK; Trivedi P; Bandopadhaya GP
    Hell J Nucl Med; 2012; 15(1):9-15. PubMed ID: 22413106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
    Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
    Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery.
    Park EK; Kim SY; Lee SB; Lee YM
    J Control Release; 2005 Dec; 109(1-3):158-68. PubMed ID: 16263189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.